secwatch.observer — SEC 8-K summary
======================================

Issuer:     CHAMPIONS ONCOLOGY, INC. (CSBR)
CIK:        0000771856
Form:       8-K
Filed at:   2021-09-13T23:59:59+00:00
Accession:  0001628280-21-018477
Event type: earnings
Sentiment:  positive
Materiality: 0.60
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Champions Oncology Q1 revenue record $11.3M, up 18% YoY; non-GAAP op income $422k
--------------------------------------------------------------------------------

- Record quarterly revenue of $11.3M, +17.9% YoY, driven by larger studies and platform expansion.
- GAAP operating loss of $175k; non-GAAP operating income of $422k, excluding $280k stock comp and $317k D&A.
- Gross margin improved to 52.0% from 44.1% as more lab work was performed internally.
- Cash position $4.0M with no debt; net cash from operations $216k in the quarter.
- Validated 6 therapeutic discovery targets; SaaS platform Lumin Bioinformatics adding new users.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/771856/000162828021018477/0001628280-21-018477-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/771856/000162828021018477/csbr-20210913.htm
  HTML page:      https://secwatch.observer/filing/0001628280-21-018477

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer